 |
| |
| May-02-19 | Upgrade |
Raymond James |
Mkt Perform → Outperform |
|
|
| Dec-14-18 | Initiated |
Barclays |
Equal Weight |
|
|
| Nov-16-18 | Initiated |
UBS |
Neutral |
$126 |
|
| Oct-30-18 | Upgrade |
The Benchmark Company |
Hold → Buy |
$125 |
|
| Jul-03-18 | Upgrade |
BofA/Merrill |
Neutral → Buy |
$88 → $97 |
|
| Mar-19-18 | Upgrade |
RBC Capital Mkts |
Sector Perform → Outperform |
|
|
| Nov-09-17 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$56 → $62 |
|
| Nov-09-17 | Downgrade |
The Benchmark Company |
Buy → Hold |
|
|
| Nov-08-17 | Reiterated |
Mizuho |
Buy |
$55 → $65 |
|
| Nov-02-17 | Upgrade |
The Benchmark Company |
Hold → Buy |
$56 |
|
| Aug-21-17 | Initiated |
BofA/Merrill |
Neutral |
|
|
| May-03-17 | Upgrade |
Mizuho |
Neutral → Buy |
$65 |
|
| May-03-17 | Reiterated |
The Benchmark Company |
Hold |
$50 → $57 |
|
| Mar-01-17 | Reiterated |
Mizuho |
Neutral |
$33 → $50 |
|
| Jan-27-17 | Initiated |
The Benchmark Company |
Hold |
$50 |
|
| Nov-09-16 | Downgrade |
Mizuho |
Buy → Neutral |
|
|
| Nov-07-16 | Upgrade |
Mizuho |
Neutral → Buy |
$47 |
|
| Aug-03-16 | Downgrade |
Mizuho |
Buy → Neutral |
$57 → $55 |
|
| May-06-16 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$41 → $48 |
|
| Apr-11-16 | Reiterated |
Mizuho |
Buy |
$49 → $57 |
|
|
|
| Jun-24-19 09:00AM | Amedisys (AMED) Upgraded to Strong Buy: Here's What You Should Know Zacks |
| Jun-21-19 11:55AM | Top Ranked Momentum Stocks to Buy for June 21st Zacks |
| 10:31AM | Zacks.com featured highlights include: Medifast, Shoe Carnival, Marine Products, Amedisys and NVR Zacks |
| Jun-20-19 07:42AM | Bet Big on DuPont Analysis With These Top 5 Picks Zacks |
| Jun-19-19 10:53AM | Heres What Hedge Funds Think About Amedisys Inc (AMED) Insider Monkey |
| Jun-17-19 08:45AM | Here is Why Growth Investors Should Buy Amedisys (AMED) Now Zacks |
| Jun-14-19 11:39AM | Zacks.com featured highlights include: Intuit, Insperity, Amedisys, Pioneer Natural and Century Casinos Zacks |
| 08:11AM | I Ran A Stock Scan For Earnings Growth And Amedisys (NASDAQ:AMED) Passed With Ease Simply Wall St. |
| Jun-13-19 08:45AM | 5 Stocks With Impressive Interest Coverage Ratio to Buy Now Zacks |
| Jun-05-19 10:42AM | Why You Should Keep An Eye On These Leading Health Care Stocks Investor's Business Daily |
| May-31-19 11:38AM | Zacks.com featured highlights include: Shoe Carnival, Ulta, Amedisys, NVR and EMCOR Zacks |
| 08:45AM | 3 Reasons Why Growth Investors Shouldn't Overlook Amedisys (AMED) Zacks |
| May-30-19 09:31AM | Amedisys (AMED) Down 9.3% Since Last Earnings Report: Can It Rebound? Zacks |
| 05:36AM | Is Trade War Scaring You? Buy 5 DuPont-Tested Quality Stocks Zacks |
| May-29-19 01:01PM | Amedisys to Present at the William Blair 2019 Growth Stock Conference GlobeNewswire |
| May-22-19 03:06PM | Amedisys to Present at the Jefferies 2019 Healthcare Conference GlobeNewswire |
| May-15-19 08:45AM | Here is Why Growth Investors Should Buy Amedisys (AMED) Now Zacks |
| 08:33AM | Do Directors Own Amedisys, Inc. (NASDAQ:AMED) Shares? Simply Wall St. |
| May-14-19 12:06PM | Amedisys to Present at the 2019 RBC Capital Markets Healthcare Conference GlobeNewswire |
| May-09-19 10:21AM | Zacks.com featured highlights include: Exantas Capital, Lamb Weston, Bristol-Myers Squibb, Amedisys and Computer Programs and Systems Zacks |
| May-08-19 04:49PM | Media Statement from Amedisys Commending the Home Health Payment Innovation Act of 2019 GlobeNewswire |
| 12:02PM | Amedisys to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference GlobeNewswire |
| 07:33AM | 5 Stocks With Upgraded Broker Ratings Worth Betting on Now Zacks |
| May-06-19 11:43PM | Edited Transcript of AMED earnings conference call or presentation 1-May-19 3:00pm GMT Thomson Reuters StreetEvents |
| 04:30PM | Amedisys Celebrates More Than 7,000 Nurses During National Nurses Week GlobeNewswire |
| May-02-19 08:54AM | Amedisys (AMED) Tops Earnings and Revenue Estimates in Q1 Zacks |
| May-01-19 06:32PM | AMEDISYS Inc (AMED) Q1 2019 Earnings Call Transcript Motley Fool -6.21% |
| 09:00AM | Amedisys (AMED) Upgraded to Buy: Here's What You Should Know Zacks |
| 09:00AM | Amedisys, Inc. to Host Earnings Call ACCESSWIRE |
| 08:35AM | One Thing To Remember About The Amedisys, Inc. (NASDAQ:AMED) Share Price Simply Wall St. |
| Apr-30-19 05:13PM | Amedisys: 1Q Earnings Snapshot Associated Press |
| 04:30PM | Amedisys Reports First Quarter 2019 Financial Results and Reaffirms 2019 Guidance GlobeNewswire |
| Apr-29-19 01:40PM | Zacks.com featured highlights include: Raytheon, Otter, Amedysis, Tutor and DMC Zacks |
| 08:45AM | Amedisys (AMED) is an Incredible Growth Stock: 3 Reasons Why Zacks |
| Apr-26-19 11:39AM | Heres What Hedge Funds Think About Amedisys Inc (AMED) Insider Monkey |
| 08:50AM | Buy These 5 Low Leverage Stocks to Avoid Huge Losses Zacks |
| Apr-24-19 09:43AM | These 5 Stocks Boast Impressive Interest Coverage Ratio Zacks |
| Apr-23-19 10:32AM | Amedisys (AMED) Reports Next Week: Wall Street Expects Earnings Growth Zacks +8.65% |
| Apr-22-19 08:28AM | Edwards Lifesciences Takes Over CAS Medical Systems for $100M Zacks |
| Apr-18-19 09:25AM | Here's Why You Should Invest in Chemed (CHE) Stock Right Now Zacks |
| Apr-17-19 08:32AM | A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED) Simply Wall St. |
| 08:18AM | Medidata Launches Acorn Artificial Intelligence Company Zacks |
| Apr-16-19 10:49AM | Hologic's Diagnostics Grows Strong, Escalating Costs a Woe Zacks -9.90% |
| Apr-15-19 03:00PM | Amedisys Announces First Quarter Earnings Release and Conference Call Date GlobeNewswire |
| Apr-12-19 03:30PM | ResMed Launches AirFit P30i Nasal Pillows Mask in the US Zacks |
| 01:29PM | Medtronic's (MDT) Study Shows Positive Results of TDD Use (revised) Zacks |
| 10:44AM | Zacks.com featured expert Kevin Matras highlights: Medifast, Foot Locker, Amedisys, Comfort Systems and CarGurus Zacks |
| Apr-11-19 10:46AM | Zacks.com featured expert Kevin Matras highlights: WellCare Health Plans, Domtar, Amedysis, Fastenal and DMC Global Zacks |
| 09:47AM | ResMed's Brightree Widens ReSupply Solution Usage for HME Zacks |
| 08:45AM | Looking for a Growth Stock? 3 Reasons Why Amedisys (AMED) is a Solid Choice Zacks |
| 08:20AM | 5 Top-Ranked Stocks to Play DuPont Analysis Zacks |
| 07:59AM | Walgreens Partners With VillageMD to Offer Primary Healthcare Zacks |
| Apr-10-19 10:13AM | Buy These 5 Low Leverage Stocks to Avoid the Perils of Debt Zacks |
| 10:10AM | Here's Why You Should Hold on to DaVita (DVA) Stock Now Zacks |
| 09:48AM | Medtronic's (MDT) Study Shows Positive Results of TDD Use Zacks |
| 09:39AM | Walgreens' Weak Market Trends a Woe, Strategic Deals to Aid Zacks |
| 09:27AM | Medtronic (MDT) Inks Value-Based Deal for Guardian Connect Zacks |
| Apr-09-19 09:13AM | Bio-Rad's (BIO) IH-500 System Secures 510(K) From the FDA Zacks |
| Apr-08-19 10:18AM | Intersect ENT Grows on Product Launch Amid Pricing Pressure Zacks |
| 10:13AM | Natus Medical to Divest Medix for Focusing on Core Business Zacks |
| 09:12AM | Medtronic's New Data for HVAD System to Boost CRHF Segment Zacks |
| 08:39AM | Orthofix (OFIX) Reports Encouraging M6-C Disc Study Results Zacks |
| Apr-05-19 09:37AM | ResMed's (RMD) Brightree Unveils Analytics Platform for HME Zacks |
| Apr-04-19 10:48AM | LabCorp (LH)-QIAGEN Form Alliance in In-Vitro Diagnostics Zacks |
| 10:45AM | ResMed (RMD) Rides on International Growth & Innovation Zacks |
| 09:33AM | Inogen (INGN) Launches One G5 Portable Oxygen Concentrator Zacks |
| 08:56AM | Myriad Genetics New Study Data to Lift Prenatal Tests' Uptake Zacks |
| Apr-03-19 09:41AM | Varian Announces Halcyon's First Successful Case in Malaysia Zacks |
| 09:10AM | Bio-Rad's Latest FDA Nod to Boost Clinical Diagnostics Arm Zacks |
| 08:01AM | A Spotlight On Amedisys, Inc.'s (NASDAQ:AMED) Fundamentals Simply Wall St. |
| Apr-02-19 11:07AM | Walgreens Boots (WBA) Q2 Earnings Lag Estimates, Margins Down Zacks |
| 09:28AM | Amedisys Closes Oklahoma-Based RoseRock Healthcare Buyout Zacks |
| 08:28AM | Here's Why You Should Invest in Illumina (ILMN) Stock Now Zacks |
| Apr-01-19 09:10AM | Here's Why You Should Invest in ResMed (RMD) Stock Right Now Zacks |
| 09:09AM | Genomic Health's New Positive Data to Boost Test Uptake Zacks |
| 07:30AM | Amedisys Closes on Acquisition of RoseRock Healthcare GlobeNewswire |
| Mar-28-19 11:02AM | Here's Why You Should Buy IDEXX Laboratories (IDXX) Stock Zacks |
| Mar-26-19 10:38AM | Buy These 5 Low Leverage Stocks for Safe Investing Zacks |
| Mar-25-19 09:47AM | 5 Stocks With Impressive Interest Coverage Ratio to Invest In Zacks |
| 07:14AM | Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)? Zacks |
| Mar-17-19 10:05AM | Did You Miss Amedisyss (NASDAQ:AMED) Whopping 723% Share Price Gain? Simply Wall St. |
| Mar-12-19 08:47AM | Here's Why You Should Add Amedisys (AMED) to Your Portfolio Zacks |
| 07:17AM | Zacks.com featured expert Kevin Matras highlights: Robert Half International, Caseys General Stores, Amedisys, Foot Locker and Comfort Systems USA Zacks |
| Mar-11-19 08:43AM | Believe in DuPont Analysis? Tap These 5 Top-Ranked Stocks Zacks |
| Mar-08-19 09:29AM | These 5 Low Leverage Stocks Are Safe Bets Zacks |
| 08:24AM | Edited Transcript of AMED earnings conference call or presentation 28-Feb-19 3:00pm GMT Thomson Reuters StreetEvents |
| Mar-05-19 07:30AM | Amedisys to Present at 29th Annual Oppenheimer Healthcare Conference GlobeNewswire |
| Feb-28-19 11:46PM | Amedisys (AMED) Q4 2018 Earnings Conference Call Transcript Motley Fool |
| 09:48PM | Amedisys Inc (AMED) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com |
| 09:36AM | Amedisys, Inc. (NASDAQ:AMED) Is Employing Capital Very Effectively Simply Wall St. |
| 07:52AM | Amedisys (AMED) Tops Earnings and Revenue Estimates in Q4 Zacks |
| Feb-27-19 05:00PM | Amedisys Reports Fourth Quarter and Year End 2018 Financial Results Issues 2019 Guidance GlobeNewswire |
| Feb-25-19 04:30PM | Amedisys Board of Directors Authorizes $100 million Stock Repurchase Program GlobeNewswire |
| 10:14AM | Zacks.com featured expert Kevin Matras highlights: Robert Half International, Caseys General Stores, Amedisys, Foot Locker and Comfort Systems USA Zacks |
| Feb-22-19 10:44AM | Quest Diagnostics Grows on Innovation Amid Reimbursement Woe Zacks |
| 09:12AM | Zacks.com featured highlights include: Merit Medical, Pinnacle West, Amedysis, Southwest Airlines and Royal Caribbean Zacks |
| 07:51AM | Have Faith in DuPont Analysis & Pick 5 Quality Stocks Zacks |
| 06:37AM | Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)? Zacks |
| Feb-21-19 09:07AM | Worried About Rate Hikes? Buy These 5 Low Leverage Stocks Zacks |
| 08:00AM | Investor Expectations to Drive Momentum within International Business Machines, Trex, ForeScout Technologies, Red Hat, Amedisys, and Atrion Discovering Underlying Factors of Influence GlobeNewswire |
|
|
|
|
| Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, social workers, and aides for its patients to complete their important personal tasks. The Hospice segment offers care that is designed to provide comfort and support for those who are dealing with a terminal illness, including heart disease, pulmonary disease, Alzheimer's, HIV/AIDS, and cancer. The Personal Care segment provides assistance for patients with the activities of daily living. As of February 27, 2019, the company owned and operated 472 care centers in 38 states. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| NETTERVILLE JAKE L | Director | Jun 13 | Sale | 118.17 | 1,863 | 220,151 | 73,700 | Jun 17 09:04 PM | | Kemmerly David L | See Remarks | Jun 10 | Option Exercise | 27.35 | 8,125 | 222,219 | 23,357 | Jun 12 09:00 PM | | Rideout Jeffrey A | Director | Jun 10 | Sale | 116.93 | 2,394 | 279,935 | 1,897 | Jun 11 09:01 PM | | Kemmerly David L | See Remarks | Jun 10 | Sale | 117.77 | 8,125 | 956,881 | 15,232 | Jun 12 09:00 PM | | Ginn Scott G | Chief Financial Officer | Jun 10 | Sale | 118.50 | 4,872 | 577,332 | 18,554 | Jun 12 09:01 PM | | Rideout Jeffrey A | Director | Jun 07 | Sale | 114.33 | 1,263 | 144,399 | 4,291 | Jun 11 09:01 PM | | Kemmerly David L | See Remarks | Jun 06 | Sale | 113.40 | 4,420 | 501,228 | 15,232 | Jun 06 09:02 PM | | North Michael Paul | Chief Information Officer | Jun 05 | Sale | 115.01 | 5,248 | 603,572 | 16,196 | Jun 06 09:02 PM | | Ginn Scott G | Chief Financial Officer | Jun 04 | Option Exercise | 0.00 | 2,500 | 0 | 25,397 | Jun 06 09:02 PM | | Kemmerly David L | See Remarks | May 30 | Option Exercise | 27.35 | 5,000 | 136,750 | 27,524 | Jun 03 09:00 PM | | Kemmerly David L | See Remarks | May 30 | Sale | 113.48 | 5,000 | 567,400 | 22,524 | Jun 03 09:00 PM | | Kemmerly David L | See Remarks | May 20 | Option Exercise | 27.35 | 5,000 | 136,750 | 27,524 | May 21 09:00 PM | | Kemmerly David L | See Remarks | May 20 | Sale | 109.96 | 5,000 | 549,800 | 22,524 | May 21 09:00 PM | | PERKINS BRUCE D | Director | May 15 | Buy | 111.84 | 2,500 | 279,597 | 22,088 | May 17 09:08 PM | | Kemmerly David L | See Remarks | May 10 | Option Exercise | 27.35 | 5,000 | 136,750 | 27,524 | May 14 09:00 PM | | Kemmerly David L | See Remarks | May 10 | Sale | 115.17 | 5,000 | 575,828 | 22,524 | May 14 09:00 PM | | Kemmerly David L | See Remarks | May 07 | Option Exercise | 27.35 | 5,000 | 136,750 | 27,524 | May 09 09:07 PM | | Kemmerly David L | See Remarks | May 07 | Sale | 118.20 | 5,000 | 591,014 | 22,524 | May 09 09:07 PM | | Pearce David B. | Chief Compliance Officer | Mar 12 | Sale | 120.01 | 4,370 | 524,444 | 13,129 | Mar 13 07:00 PM | | Gerard Christopher | Chief Operating Officer | Mar 11 | Sale | 118.96 | 2,500 | 297,400 | 25,731 | Mar 13 07:00 PM | | Rideout Jeffrey A | Director | Mar 04 | Sale | 121.58 | 1,411 | 171,549 | 4,257 | Mar 06 07:06 PM | | Kemmerly David L | See Remarks | Feb 20 | Option Exercise | 0.00 | 3,125 | 0 | 21,187 | Feb 22 09:00 PM | | Brunecz Sharon | Chief Human Resources Officer | Feb 20 | Option Exercise | 0.00 | 4,193 | 0 | 12,579 | Feb 22 09:00 PM | | Kusserow Paul B. K. | CEO and President | Feb 20 | Option Exercise | 0.00 | 18,750 | 0 | 66,940 | Feb 22 09:01 PM | | Ginn Scott G | Chief Financial Officer | Feb 20 | Option Exercise | 0.00 | 8,982 | 0 | 21,756 | Feb 22 09:01 PM | | Gerard Christopher | Chief Operating Officer | Feb 20 | Option Exercise | 0.00 | 8,091 | 0 | 26,932 | Feb 22 09:00 PM | | North Michael Paul | Chief Information Officer | Feb 20 | Option Exercise | 0.00 | 1,875 | 0 | 22,251 | Feb 22 09:00 PM | | Pearce David B. | Chief Compliance Officer | Feb 20 | Option Exercise | 0.00 | 5,702 | 0 | 16,712 | Feb 22 09:16 PM | | Pearce David B. | Chief Compliance Officer | Dec 24 | Sale | 106.61 | 410 | 43,710 | 11,010 | Dec 27 09:01 PM | | North Michael Paul | Chief Information Officer | Dec 12 | Option Exercise | 36.04 | 7,520 | 270,983 | 29,023 | Dec 14 09:00 PM | | Kemmerly David L | See Remarks | Dec 12 | Option Exercise | 27.35 | 3,125 | 85,469 | 21,177 | Dec 14 09:12 PM | | Kemmerly David L | See Remarks | Dec 12 | Sale | 133.82 | 3,125 | 418,188 | 18,052 | Dec 14 09:12 PM | | North Michael Paul | Chief Information Officer | Dec 12 | Sale | 134.79 | 7,520 | 1,013,621 | 21,503 | Dec 14 09:00 PM | | Pearce David B. | Chief Compliance Officer | Nov 23 | Sale | 119.25 | 398 | 47,462 | 11,420 | Nov 27 08:01 PM | | NETTERVILLE JAKE L | Director | Nov 16 | Sale | 126.64 | 1,000 | 126,640 | 74,266 | Nov 19 09:00 PM | | North Michael Paul | Chief Information Officer | Nov 15 | Option Exercise | 32.56 | 5,875 | 191,290 | 27,378 | Nov 19 09:00 PM | | NETTERVILLE JAKE L | Director | Nov 15 | Sale | 121.28 | 2,394 | 290,344 | 75,266 | Nov 19 09:00 PM | | North Michael Paul | Chief Information Officer | Nov 15 | Sale | 120.26 | 5,875 | 706,539 | 21,503 | Nov 19 09:00 PM | | North Michael Paul | Chief Information Officer | Nov 14 | Option Exercise | 32.56 | 3,261 | 106,178 | 24,764 | Nov 14 09:00 PM | | Kemmerly David L | See Remarks | Nov 14 | Option Exercise | 27.35 | 3,125 | 85,469 | 21,177 | Nov 16 09:00 PM | | Kemmerly David L | See Remarks | Nov 14 | Sale | 116.88 | 3,125 | 365,240 | 18,052 | Nov 16 09:00 PM | | North Michael Paul | Chief Information Officer | Nov 14 | Sale | 116.36 | 3,261 | 379,450 | 21,503 | Nov 14 09:00 PM | | North Michael Paul | Chief Information Officer | Nov 13 | Option Exercise | 32.56 | 100 | 3,256 | 21,603 | Nov 14 09:00 PM | | North Michael Paul | Chief Information Officer | Nov 13 | Sale | 118.06 | 100 | 11,806 | 21,503 | Nov 14 09:00 PM | | Ginn Scott G | Chief Financial Officer | Nov 12 | Option Exercise | 27.35 | 5,625 | 153,844 | 20,414 | Nov 14 09:00 PM | | North Michael Paul | Chief Information Officer | Nov 12 | Option Exercise | 32.56 | 2,264 | 73,716 | 23,767 | Nov 14 09:00 PM | | North Michael Paul | Chief Information Officer | Nov 12 | Sale | 119.30 | 2,264 | 270,095 | 21,503 | Nov 14 09:00 PM | | Ginn Scott G | Chief Financial Officer | Nov 12 | Sale | 117.41 | 7,640 | 896,999 | 12,774 | Nov 14 09:00 PM | | Kemmerly David L | See Remarks | Nov 09 | Option Exercise | 27.35 | 3,125 | 85,469 | 21,177 | Nov 09 09:00 PM | | Gerard Christopher | Chief Operating Officer | Nov 09 | Option Exercise | 46.35 | 7,892 | 365,794 | 29,429 | Nov 14 09:03 PM | | Hall Linda J. | Director | Nov 09 | Sale | 120.00 | 5,256 | 630,720 | 17,169 | Jan 09 09:00 PM | | Gerard Christopher | Chief Operating Officer | Nov 09 | Sale | 119.02 | 7,892 | 939,286 | 21,537 | Nov 14 09:03 PM | | Kemmerly David L | See Remarks | Nov 09 | Sale | 120.41 | 3,125 | 376,293 | 18,052 | Nov 09 09:00 PM | | Kemmerly David L | See Remarks | Nov 07 | Option Exercise | 27.35 | 3,375 | 92,306 | 21,427 | Nov 09 09:00 PM | | Kemmerly David L | See Remarks | Nov 07 | Sale | 117.44 | 3,375 | 396,360 | 18,052 | Nov 09 09:00 PM | | Pearce David B. | Chief Compliance Officer | Sep 25 | Sale | 121.71 | 398 | 48,441 | 11,818 | Sep 26 09:00 PM | | Pearce David B. | Chief Compliance Officer | Jul 25 | Sale | 94.18 | 398 | 37,484 | 12,216 | Jul 27 08:00 PM |
|
|
|
|
|
|
